Lexaria Bioscience SG&A Expense (Quarterly) Insights

Lexaria Bioscience Corp (LEXX)

3.02 +0.08 (+2.72%) USD | NASDAQ | Sep 27, 16:00

2.99 -0.03 (-0.99%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2006. Upgrade now.

Date	Value
May 31, 2024	1.254M
February 29, 2024	0.5672M
November 30, 2023	0.7111M
August 31, 2023	0.6444M
May 31, 2023	0.8252M
February 28, 2023	0.6445M
November 30, 2022	0.9479M
August 31, 2022	0.4623M
May 31, 2022	1.747M
February 28, 2022	1.197M
November 30, 2021	1.553M
August 31, 2021	0.8736M
May 31, 2021	2.256M
February 28, 2021	1.090M
November 30, 2020	0.752M
August 31, 2020	1.001M
May 31, 2020	1.342M
February 29, 2020	0.8273M
November 30, 2019	0.802M
August 31, 2019	0.9455M
May 31, 2019	0.9948M
February 28, 2019	1.090M
November 30, 2018	0.6132M
August 31, 2018	1.106M
May 31, 2018	3.466M

Date	Value
February 28, 2018	1.459M
November 30, 2017	0.4829M
August 31, 2017	0.6312M
May 31, 2017	0.3532M
February 28, 2017	0.4521M
November 30, 2016	0.3964M
August 31, 2016	0.336M
May 31, 2016	0.2487M
February 29, 2016	0.2394M
November 30, 2015	0.392M
August 31, 2015	0.50M
May 31, 2015	0.4979M
February 28, 2015	0.4501M
November 30, 2014	0.315M
July 31, 2014	0.5795M
April 30, 2014	0.4808M
January 31, 2014	0.1174M
October 31, 2013	0.0712M
July 31, 2013	0.0936M
April 30, 2013	0.086M
January 31, 2013	0.1215M
October 31, 2012	0.0922M
July 31, 2012	0.1416M
April 30, 2012	0.1621M
January 31, 2012	0.1695M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.4623M

Minimum

Aug 2022

2.256M

Maximum

May 2021

1.026M

Average

0.8736M

Median

Aug 2021

SG&A Expense (Quarterly) Benchmarks